Skip to content

Home pulmonary rehabilitation improved measured outcomes in a COPD trial

Nurse-supported rehabilitation improved walking compared with standard care, with anxiety and sleep benefits also reported; the abstract gives no effect sizes.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

The home rehabilitation group improved walking capacity compared with standard care. The abstract also reports reduced anxiety and better overall sleep quality at the final assessment. No intervention-related adverse events were reported. However, it does not show how large these changes were or whether the reported benefits lasted beyond the programme.

Keep in mind

The trial was unblinded and conducted at a single centre, with results reported for participants who completed follow-up. Without effect sizes or longer follow-up, the size and durability of the benefits remain unclear.

THE NUMBERS, WITH CONTEXT

What researchers found

p < 0.001

Improvement in 6-minute walk distance

Rehabilitation versus standard care at week 8; the abstract does not report the size of the distance difference.

Int J Nurs Pract, 2025 · Original source ↓

A combined rehabilitation programme

The programme combined breathing exercises, resistance exercise and structured education, with initial remote supervision and ongoing nurse contact. Because it was a combined programme, the trial cannot tell which component accounted for the reported differences.

Interpreting the additional outcomes

Anxiety and sleep quality were measured with questionnaires, while breathlessness was another reported outcome. Improvements across these measures add context to the walking result, but statistical significance alone does not reveal how noticeable the changes were.

CHECK THE ORIGINAL

The original publication

Effects of Home-Based Pulmonary Rehabilitation on Walking, Anxiety and Sleep in Patients With Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial.

Coşkun S, Şimşek NY, Arslan Y
Int J Nurs Pract · 2025

PubMed ID
41351250
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.